Concepedia

Andrei Breazna

AB

Statistics

Publications

26

Citations

3.7K

H-Index

23

Active since

2006

Affiliations

Pfizer (United States)(Current)

University of California, San Francisco

University of Amsterdam

Amsterdam UMC Location University of Amsterdam

San Francisco General Hospital

Andrei Breazna is an author at Pfizer (United States) specializing in medicine, cardiovascular pharmacotherapy, and lipid-lowering therapy.

ORCID

Publications per year

2006–2018

26

Publications

26

Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes

James Shepherd, Philip J. Barter, Rafael Carmena et al. · Diabetes Care · 2006 · 528 citations · Full text

, , +17

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease

Howard Feldman, Rachelle S. Doody, Miia Kivipelto et al. · Neurology · 2010 · 433 citations

, , +17

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

David D. Waters, Jennifer E. Ho, David A. DeMicco et al. · Journal of the American College of Cardiology · 2011 · 329 citations

, , +9

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease

James Shepherd, John J.P. Kastelein, Vera Bittner et al. · Journal of the American College of Cardiology · 2008 · 303 citations

, , +16

Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease

James Shepherd, John J.P. Kastelein, Vera Bittner et al. · Clinical Journal of the American Society of Nephrology · 2007 · 271 citations

, , +14

1–5 of 26